TriSalus Life Sciences (TLSI) Change in Inventory (2022 - 2026)
TriSalus Life Sciences' (TLSI) quarterly Change in Inventory came in at $701000.0 in Q1 2026, up 514.91% year-on-year from $114000.0 in Q1 2025, and up 452.26% quarter-over-quarter from -$199000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Change in Inventory (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Change in Inventory history runs 5 years deep, the most recent figure standing at $701000.0 for Q1 2026.
- On a quarterly basis, Change in Inventory rose 514.91% year-over-year to $701000.0 in Q1 2026; TTM through Mar 2026 was -$384000.0, a 130.74% decrease from a year earlier, with the FY2025 full-year figure at -$971000.0, down 164.6% from the prior year.
- Change in Inventory improved to $701000.0 in Q1 2026 per TLSI's latest filing, from -$199000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $915000.0 in Q4 2023 and bottomed at -$531000.0 in Q3 2025.
- The 5-year median for Change in Inventory is $149500.0 (2022), against an average of $177928.6.
- Across the five-year window, Change in Inventory sank 514.58% in 2025 and soared 514.91% in 2026, its largest moves.
- Year by year, Change in Inventory stood at $185000.0 in 2022, then soared by 394.59% to $915000.0 in 2023, then plunged by 94.75% to $48000.0 in 2024, then sank by 514.58% to -$199000.0 in 2025, then jumped by 452.26% to $701000.0 in 2026.
- Per Business Quant, the three latest TLSI Change in Inventory figures stand at $701000.0 (Q1 2026), -$199000.0 (Q4 2025), and -$531000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TriSalus Life Sciences | 220.07 Mn | 163.52 Mn | 7.67 Mn | 701,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 701,000.00 |
| Mar 31, 2026 | 701,000.00 |
| Dec 31, 2025 | -199,000.00 |
| Dec 31, 2025 | -199,000.00 |
| Sep 30, 2025 | -531,000.00 |
| Sep 30, 2025 | -531,000.00 |
| Jun 30, 2025 | -355,000.00 |
| Jun 30, 2025 | -355,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 556,000.00 |
| Sep 30, 2024 | 556,000.00 |
| Jun 30, 2024 | 531,000.00 |
| Jun 30, 2024 | 531,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 915,000.00 |
| Dec 31, 2023 | 915,000.00 |